• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ADMA Biologics Inc - Common Stock (NQ:ADMA)

    14.68 +0.36 (+2.48%)
    Streaming Delayed Price Updated: 9:42 AM EDT, Mar 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 220,084
    Open 14.67
    Bid (Size) 14.66 (300)
    Ask (Size) 14.69 (200)
    Prev. Close 14.32
    Today's Range 14.53 - 14.84
    52wk Range 13.76 - 25.67
    Shares Outstanding 196,357,149
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges ↗
    Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline. 
    Via The Motley Fool
    News headline image
    ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
    From ADMA Biologics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -17.9%
    -17.9%
    1 Month
    -8.9%
    -8.9%
    3 Month
    -26.2%
    -26.2%
    6 Month
    -8.5%
    -8.5%
    1 Year
    -27.8%
    -27.8%

    More News

    Read More
    News headline image
    ADMA Biologics (ADMA) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    ADMA Biologics Inc (NASDAQ:ADMA) Reports Record 2025 Results Driven by ASCENIV, Provides 2026 Outlook ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 6, 2025 ↗
    Via Benzinga
    News headline image
    Is ADMA Biologics Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth ↗
    Via The Motley Fool
    Topics Energy
    News headline image
    Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate ↗
    Via Chartmill
    News headline image
    ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why ↗
    Via The Motley Fool
    News headline image
    ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Adma Biologics (ADMA) Q2 Revenue Up 14% ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is ADMA Biologics Inc - Common Stock publicly traded?
    Yes, ADMA Biologics Inc - Common Stock is publicly traded.
    What exchange does ADMA Biologics Inc - Common Stock trade on?
    ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ADMA Biologics Inc - Common Stock?
    The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
    What is the current price of ADMA Biologics Inc - Common Stock?
    The current price of ADMA Biologics Inc - Common Stock is 14.68
    When was ADMA Biologics Inc - Common Stock last traded?
    The last trade of ADMA Biologics Inc - Common Stock was at 03/23/26 09:42 AM ET
    What is the market capitalization of ADMA Biologics Inc - Common Stock?
    The market capitalization of ADMA Biologics Inc - Common Stock is 2.88B
    How many shares of ADMA Biologics Inc - Common Stock are outstanding?
    ADMA Biologics Inc - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.